Speaking to this paper yesterday, Ministry of Health and Social Welfare's head of communication unit Mr Nsachris Mwamaja said the document would be used by a team of experts to examine the guidelines before making any decision.
However, Mr Mwamaja said, according to the abridged copy of the document, Tanzania has already started implementing some of the recommendations issued by WHO.
He said for instance that the country’s malaria treatment policy is discouraging the use of oral artemisinin-based monotherappy as the new WHO malaria guidelines advocates. The global health watchdog has released a new Malaria treatment guidelines as well as the first guideline on procurement of safe and effective medicines, in a move to intensify the campaign against the leading killer disease.
The new guidelines also endorse the use of the artemisinin-based combination therapies (ACTs), as the major treatment regime for malaria while discouraging the use of artemisinin-based monotherapy since its use will hasten the development of parasite resistance.
The WHO also cautions in its new guidelines on the need for proper application of the recommended treatments.
“In recent years, a new type of treatment called artemisinin-based combination therapy (ACTs) has transformed the treatment of malaria, but if not used properly, the medicine could become ineffective,” says the WHO statement.
Written by By Frank Kimboy, thecitizen.co.tz